Tracking Pancreas Function Changes in IPMN Patients
Part of Digestive system clinical trials.
This study follows patients with IPMN (a type of pancreatic growth) who are already getting regular imaging scans. Researchers want to understand whether changes in how well the pancreas makes digestive enzymes can help predict how the condition progresses and when intervention might be needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with IPMN (a cyst or growth in the pancreas)
- You are currently receiving regular imaging scans (ultrasound, CT, or MRI) to monitor your pancreas
- You have not had pancreatic surgery before
- You do not have chronic pancreatitis (long-term inflammation of the pancreas)
- You do not have pancreatic cancer or other conditions causing pancreatic enzyme problems unrelated to IPMN
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “biomarkers,” meaning measurable signs in the blood, in people diagnosed with intraductal papillary mucinous neoplasm (IPMN). It aims to better understand what changes happen in this condition and may help future diagnosis or monitoring.
This study looks for new markers in the blood or tissues of people with a pancreatic condition called IPMN. The goal is to find better ways to predict if IPMN might turn into cancer and to help choose the best treatment.
This trial studies whether blood markers can help predict which pancreatic IPMNs are likely to become cancerous. If successful, it could help doctors decide when surgery is needed.
This trial looks for markers in cyst fluid and tissue to help identify which IPMN growths are becoming invasive (spreading). It may help doctors decide who needs surgery.
This study looks at how GLP-1 receptor agonists (medications used for diabetes and weight loss) might affect people with IPMN (a type of pancreatic cyst). The goal is to see if these drugs change the size or growth of the cysts.
This trial tests whether regular MRI scans can help catch pancreatic cancer early in people who have intermediate- or high-risk IPMN (a type of pancreatic cyst). It aims to find cancer sooner to improve treatment options.
Hear when a new Intraductal Papillary Mucinous Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.